14573672falsePharmaceutical services2025-02-012026-01-31http://www.companieshouse.gov.uk/2025-01-31http://www.companieshouse.gov.uk/pt:ShareCapital2025-01-31http://www.companieshouse.gov.uk/cd:Director12025-02-012026-01-31http://www.companieshouse.gov.uk/pt:ShareCapital2026-01-31http://www.companieshouse.gov.uk/pt:FurnitureFittings2025-01-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2025-01-31http://www.companieshouse.gov.uk/pt:FurnitureFittings2026-01-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12025-02-012026-01-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2026-01-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2025-02-012026-01-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass22025-02-012026-01-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2025-02-012026-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2026-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-01-31http://www.companieshouse.gov.uk/2025-02-012026-01-31http://www.companieshouse.gov.uk/2025-01-31http://www.companieshouse.gov.uk/cd:FRS1022025-02-012026-01-31http://www.companieshouse.gov.uk/2026-01-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2025-02-012026-01-31http://www.companieshouse.gov.uk/cd:FilletedAccounts2025-02-012026-01-31iso4217:GBPxbrli:sharesxbrli:pure

Registered number: 14573672

Sagir Pharmaceuticals Limited

ACCOUNTS

FOR THE YEAR ENDED 31/01/2026

Prepared By:

EMA2 Ltd

110

HIgh street

Earls colne

Colchester

CO6 2QX

Sagir Pharmaceuticals Limited

ACCOUNTS

FOR THE YEAR ENDED 31/01/2026

DIRECTORS

Nuzat Sagir

REGISTERED OFFICE

107 Uplands Road

Woodford Green

IG8 8JP

COMPANY DETAILS

Private company limited by shares registered in EW - England and Wales, registered number 14573672

ACCOUNTANTS

EMA2 Ltd

110

HIgh street

Earls colne

Colchester

CO6 2QX

Sagir Pharmaceuticals Limited

ACCOUNTS
FOR THEYEARENDED31/01/2026
CONTENTS
		Page
Directors' Report		-
Statement Of Comprehensive Income		-
Balance Sheet		3
Notes To The Accounts		4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account		-
Profit And Loss Account Summaries		-

Sagir Pharmaceuticals Limited

BALANCE SHEET AT 31/01/2026
						2026				2025
		Notes				£				£
FIXED ASSETS
Tangible assets		3				1,124				1,640
CURRENT ASSETS
Cash at bank and in hand				323				20
				323				20
CREDITORS: Amounts falling due within one year		4		13,625				1,591
NET CURRENT LIABILITIES						(13,302)				(1,571)
TOTAL ASSETS LESS CURRENT LIABILITIES						(12,178)				69
CAPITAL AND RESERVES
Called up share capital		5				5				5
Profit and loss account						(12,183)				64
SHAREHOLDERS' FUNDS						(12,178)				69
For the year ending 31/01/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 29/06/26 and signed on their behalf by
.............................
Nuzat Sagir
Director

Sagir Pharmaceuticals Limited

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 31/01/2026

1. ACCOUNTING POLICIES

1a. Basis Of Accounting

The accounts have been prepared under the historical cost convention.

The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .

1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Fixtures and Fittings		Straight Line 20%%
Equipment		Straight Line 20%%

2. EMPLOYEES
				2026		2025
				No.		No.
Average number of employees				2		2

3. TANGIBLE FIXED ASSETS
		Fixtures
		and Fittings		Equipment		Total
		£		£		£
Cost
At 01/02/2025		1,816		764		2,580
At 31/01/2026		1,816		764		2,580
Depreciation
At 01/02/2025		558		382		940
For the year		363		153		516
At 31/01/2026		921		535		1,456
Net Book Amounts
At 31/01/2026		895		229		1,124
At 31/01/2025		1,258		382		1,640

Sagir Pharmaceuticals Limited

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
				2026		2025
				£		£
Directors current account				13,625		1,591
				13,625		1,591

5. SHARE CAPITAL				2026		2025
				£		£
Allotted, issued and fully paid:
1 of £1 each				1
4 of £1 each				4
				5		5